Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 9Completed 9Unknown 3Active not recruiting 3Withdrawn 2Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 33Gastrointestinal 28CNS 23Genitourinary 17Dermatologic 11Head & Neck 9Breast 6Sarcoma 4Other solid neoplasm 3Tumor-Agnostic 2Other neoplasm 1Gynecologic 1Endocrine 1

Conditions

Neoplasm Metastasis 2

Interventions

Gemcitabine 13pembrolizumab 12Capecitabine 9Irinotecan 8Erlotinib Hydrochloride 8Carboplatin 8Blood Specimen Collection 8Nivolumab 7Docetaxel 7Cisplatin 7Cetuximab 7Paclitaxel 6Everolimus 6130-nm albumin-bound paclitaxel 6vadimezan 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cyclophosphamide 5trametinib 4Leucovorin 4Lapatinib 4Ipilimumab 4Bevacizumab 4Albumin-Bound Paclitaxel 4temsirolimus 3atezolizumab 3abemaciclib 3Trastuzumab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Radiosurgery × Tumor-Agnostic × Clear all
NCT02353000 2020-06-01

WBRTvsSRS

Maastricht Radiation Oncology

Phase NA Terminated
31 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00802659 2014-12-05

A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain

Washington University School of Medicine

Phase NA Terminated
2 enrolled 4 charts
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡